Načítá se...
Immunotherapy expands and maintains the function of high affinity tumor infiltrating CD8 T cells in situ
Cancer cells harbor high affinity tumor-associated antigens capable of eliciting potent anti-tumor T cell responses yet detecting these polyclonal T cells is challenging. Therefore, surrogate markers of T cell activation such as CD69, CD44, and PD-1 have been used. We report here that in mice, expre...
Uloženo v:
| Vydáno v: | J Immunol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5010950/ https://ncbi.nlm.nih.gov/pubmed/27503208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1502659 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|